Trials / Completed
CompletedNCT04176211
The Impact of Myasthenia Gravis in the Real World
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,847 (actual)
- Sponsor
- Vitaccess Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An international, non-interventional, prospective, community recruited, longitudinal, lifestyle study which aims to collect Real-World Evidence (RWE) from people living with myasthenia gravis (MG) in order to map the disease's natural history, its burden on patients and their families, its treatment, as well as its medical, social and pharmacoeconomic impact.
Detailed description
Data was collected from people with MG using the MyRealWorld™ RWE platform , developed by the healthcare digital research company, Vitaccess. Participants downloaded a 'bring your own device' (BYOD) study app, MyRealWorld™ MG, onto their smartphones, which they used to enter data and complete surveys about their MG.
Conditions
Timeline
- Start date
- 2019-12-12
- Primary completion
- 2024-05-31
- Completion
- 2024-05-31
- First posted
- 2019-11-25
- Last updated
- 2024-06-03
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04176211. Inclusion in this directory is not an endorsement.